FDA Bans CFC Inhalers, Walmart Offers Low-Cost Alternative
An FDA mandate that came into effect on Dec. 31 dictates that all albuterol metered-dose asthma inhalers marketed in the U.S. must use hydrofluroalkane (HFA) propellants, as opposed to chlorofluorocarbon (CFC) propellants.
Most manufacturers, like GlaxoSmithKline (GSK) and Schering-Plough, hurried to make the transition and have increased production to ensure an adequate supply of HFA inhalers. Armstrong Pharmaceuticals has not yet done so, the FDA said.
Rescue inhalers can be costly: some HFA inhalers may sell for as much as $60 for certain brands. To make the life-saving medication affordable, Walmart is going to sell the ReliOn Ventolin HFA inhaler for $9.
Energy Manager News
- 30 Environmental Advocacy Groups Call on NARUC for Holistic Rate-Setting Guidelines
- New York State’s Summer of Energy
- Chicago Church Strives for Energy Efficiency
- Small, Medium Size Commercial Building Efficiency Market to Grow
- ERC: Price Benchmark Trends Week Ending June 24, 2016
- FERC Rules Against Tri-State Fee on Local Renewable Power
- Marin Clean Energy to Reduce Rates and Expand Service Area in September
- Drama Aside, Tesla’s Acquisition of SolarCity Makes Sense